Glaxo Agrees to Settle More than 20,000 Avandia Lawsuits


GlaxoSmithKline in January agreed to settle more than 20,000 lawsuits alleging its diabetes medication Avandia led to heart attacks.

The resolution was reached amid court-ordered mediation. GlaxoSmithKline, the United Kingdom’s largest pharmaceutical manufacturer, in November 2011 was ordered to pay $3 billion to resolve government claims that the company illegally marketed Avandia and other drugs.

Avandia (rosiglitazone) has been primarily used in the treatment of type 2 diabetes mellitus, which is also referred to as adult-onset diabetes. Avandia worked by helping the body better use naturally occurring insulin.

However, the medication increasingly became associated with side-effects including heart attacks, hepatitis, macular edema and low blood sugar.

Last year, there were reports that GlaxoSmithKline agreed to pay approximately $700 million to settle more than 15,000 cases alleging that Avandia caused heart attacks and strokes. Other cases remain pending in state courts across the United States.

In 2010, GlaxoSmithKline said it would halt promotion of Avandia after European regulators withdrew the drug from the marketplace and the United States limited its sales.

If you believe you suffered harm as a result of taking Avandia or another prescription drug that you used as directed, an experienced product liability attorney may be able to help you pursue financial compensation, including money for related medical expenses, lost wages, and pain and suffering.

Please contact to locate a dangerous pharmaceuticals attorney near you.